| The classification of glomerulonephritis in systemic lupus erythematosus revisited JJ Weening, VD D'agati, MM Schwartz, SV Seshan, CE Alpers, GB Appel, ... Kidney international 65 (2), 521-530, 2004 | 4232 | 2004 |
| The Banff 97 working classification of renal allograft pathology LC Racusen, K Solez, RB Colvin, SM Bonsib, MC Castro, T Cavallo, ... Kidney international 55 (2), 713-723, 1999 | 3836 | 1999 |
| Banff 07 classification of renal allograft pathology: updates and future directions K Solez, RB Colvin, LC Racusen, M Haas, B Sis, M Mengel, PF Halloran, ... American journal of transplantation 8 (4), 753-760, 2008 | 2351 | 2008 |
| Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China H Su, M Yang, C Wan, LX Yi, F Tang, HY Zhu, F Yi, HC Yang, AB Fogo, ... Kidney international 98 (1), 219-227, 2020 | 2183 | 2020 |
| Pathologic classification of diabetic nephropathy TWC Tervaert, AL Mooyaart, K Amann, AH Cohen, HT Cook, ... Journal of the American Society of Nephrology 21 (4), 556-563, 2010 | 1903 | 2010 |
| Antibody‐mediated rejection criteria–an addition to the Banff′ 97 classification of renal allograft rejection LC Racusen, RB Colvin, K Solez, MJ Mihatsch, PF Halloran, ... American Journal of Transplantation 3 (6), 708-714, 2003 | 1383 | 2003 |
| The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification AWG of the International, IAN Network, DC Cattran, R Coppo, HT Cook, ... Kidney international 76 (5), 534-545, 2009 | 1240 | 2009 |
| Oxford classification of IgA nephropathy 2016: an update from the IgA nephropathy classification working group H Trimarchi, J Barratt, DC Cattran, HT Cook, R Coppo, M Haas, ZH Liu, ... Kidney international 91 (5), 1014-1021, 2017 | 1053 | 2017 |
| Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy A Levin, M Tonelli, J Bonventre, J Coresh, JA Donner, AB Fogo, CS Fox, ... The Lancet 390 (10105), 1888-1917, 2017 | 1028 | 2017 |
| Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor T Ichiki, PA Labosky, C Shiota, S Okuyama, Y Imagawa, A Fogo, ... Nature 377 (6551), 748-750, 1995 | 1027 | 1995 |
| The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility AWG of the International, IAN Network, ISD Roberts, HT Cook, S Troyanov, ... Kidney international 76 (5), 546-556, 2009 | 1009 | 2009 |
| Pathologic classification of focal segmental glomerulosclerosis: a working proposal V D D'Agati, AB Fogo, JA Bruijn, JC Jennette American journal of kidney diseases 43 (2), 368-382, 2004 | 989 | 2004 |
| Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes … IM Bajema, S Wilhelmus, CE Alpers, JA Bruijn, RB Colvin, HT Cook, ... Kidney international 93 (4), 789-796, 2018 | 891 | 2018 |
| C3 glomerulopathy: consensus report MC Pickering, VD D'agati, CM Nester, RJ Smith, M Haas, GB Appel, ... Kidney international 84 (6), 1079-1089, 2013 | 747 | 2013 |
| Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes”(KDIGO) Controversies Conference THJ Goodship, HT Cook, F Fakhouri, FC Fervenza, V Frémeaux-Bacchi, ... Kidney international 91 (3), 539-551, 2017 | 741 | 2017 |
| The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell–and antibody‐mediated rejection A Loupy, M Haas, C Roufosse, M Naesens, B Adam, M Afrouzian, ... American Journal of Transplantation 20 (9), 2318-2331, 2020 | 674 | 2020 |
| Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1 LJ Ma, SL Mao, KL Taylor, T Kanjanabuch, YF Guan, YH Zhang, ... Diabetes 53 (2), 336-346, 2004 | 539 | 2004 |
| IgA nephropathy KN Lai, SCW Tang, FP Schena, J Novak, Y Tomino, AB Fogo, ... Nature reviews Disease primers 2 (1), 1-20, 2016 | 515 | 2016 |
| Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease RJ Johnson, SD Kivlighn, YG Kim, S Suga, AB Fogo American journal of kidney diseases 33 (2), 225-234, 1999 | 498 | 1999 |
| AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function LL Dugan, YH You, SS Ali, M Diamond-Stanic, S Miyamoto, AE DeCleves, ... The Journal of clinical investigation 123 (11), 2013 | 494 | 2013 |
